Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 2
2003 1
2007 1
2009 3
2010 2
2011 2
2012 4
2013 4
2015 1
2017 1
2020 1
2021 1
2022 3
2023 3
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga J; APHINITY Steering Committee and Investigators. von Minckwitz G, et al. N Engl J Med. 2017 Jul 13;377(2):122-131. doi: 10.1056/NEJMoa1703643. Epub 2017 Jun 5. N Engl J Med. 2017. PMID: 28581356 Free PMC article. Clinical Trial.
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
Baselga J, Cortés J, Kim SB, Im SA, Hegg R, Im YH, Roman L, Pedrini JL, Pienkowski T, Knott A, Clark E, Benyunes MC, Ross G, Swain SM; CLEOPATRA Study Group. Baselga J, et al. N Engl J Med. 2012 Jan 12;366(2):109-19. doi: 10.1056/NEJMoa1113216. Epub 2011 Dec 7. N Engl J Med. 2012. PMID: 22149875 Free PMC article. Clinical Trial.
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.
Swain SM, Baselga J, Kim SB, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Schneeweiss A, Heeson S, Clark E, Ross G, Benyunes MC, Cortés J; CLEOPATRA Study Group. Swain SM, et al. N Engl J Med. 2015 Feb 19;372(8):724-34. doi: 10.1056/NEJMoa1413513. N Engl J Med. 2015. PMID: 25693012 Free PMC article. Clinical Trial.
Erythropoietin pharmacology.
Jurado García JM, Torres Sánchez E, Olmos Hidalgo D, Alba Conejo E. Jurado García JM, et al. Among authors: alba conejo e. Clin Transl Oncol. 2007 Nov;9(11):715-22. doi: 10.1007/s12094-007-0128-y. Clin Transl Oncol. 2007. PMID: 18055326 Review.
Oncogene-addicted solid tumors and microbiome-lung cancer as a main character: a narrative review.
Guardamagna M, Meyer ML, Berciano-Guerrero MÁ, Mesas-Ruiz A, Cobo-Dols M, Perez-Ruiz E, Cantero Gonzalez A, Lavado-Valenzuela R, Barragán I, Oliver J, Garrido-Aranda A, Alvarez M, Rueda-Dominguez A, Queipo-Ortuño MI, Alba Conejo E, Benitez JC. Guardamagna M, et al. Among authors: alba conejo e. Transl Lung Cancer Res. 2024 Aug 31;13(8):2050-2066. doi: 10.21037/tlcr-24-216. Epub 2024 Aug 6. Transl Lung Cancer Res. 2024. PMID: 39263011 Free PMC article. Review.
Initialization of adjuvant hormonal treatment for breast cancer.
Martínez Guisado A, Sánchez Muñoz A, de la Cabeza Lomas Garrido M, Ruíz Borrego M, Bayo Calero J, de Toro Salas R, González Mancha R, de la Haba Rodríguez J, Alba Conejo E. Martínez Guisado A, et al. Among authors: alba conejo e. Adv Ther. 2011 Sep;28 Suppl 6:66-84. doi: 10.1007/s12325-011-0039-8. Epub 2011 Sep 16. Adv Ther. 2011. PMID: 21922396 Review.
Targeted therapy of metastatic breast cancer.
Sánchez-Muñoz A, Pérez-Ruiz E, Jiménez B, Ribelles N, Márquez A, García-Ríos I, Alba Conejo E. Sánchez-Muñoz A, et al. Among authors: alba conejo e. Clin Transl Oncol. 2009 Oct;11(10):643-50. doi: 10.1007/s12094-009-0419-6. Clin Transl Oncol. 2009. PMID: 19828406 Review.
Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES study.
Guerrero-Zotano Á, Pérez-García JM, Ruiz-Borrego M, Bermejo B, Gil-Gil M, de la Haba J, Alba Conejo E, Quiroga V, Carañana V, Urruticoechea A, Morales S, Bellet M, Antón A, Fernández-Abad M, Sánchez-Rovira P, Calabuig L, Pérez-Escuredo J, Sampayo-Cordero M, Cortés J, Llombart-Cussac A. Guerrero-Zotano Á, et al. Among authors: alba conejo e. ESMO Open. 2024 Oct;9(10):103733. doi: 10.1016/j.esmoop.2024.103733. Epub 2024 Sep 30. ESMO Open. 2024. PMID: 39353215 Free PMC article.
New insights into the role of the immune microenvironment in breast carcinoma.
de la Cruz-Merino L, Barco-Sánchez A, Henao Carrasco F, Nogales Fernández E, Vallejo Benítez A, Brugal Molina J, Martínez Peinado A, Grueso López A, Ruiz Borrego M, Codes Manuel de Villena M, Sánchez-Margalet V, Nieto-García A, Alba Conejo E, Casares Lagar N, Ibáñez Martínez J. de la Cruz-Merino L, et al. Among authors: alba conejo e. Clin Dev Immunol. 2013;2013:785317. doi: 10.1155/2013/785317. Epub 2013 Jun 3. Clin Dev Immunol. 2013. PMID: 23861693 Free PMC article. Review.
28 results